Table 2.
Univariate analysis of possible prognostic factors associated with responses to docetaxel, oxaliplatin and S-1
|
Parameter
|
DCR
|
PD
|
P value
|
|
| Sex | 0.664 | |||
| Male | 70 (82.4) | 7 (77.8) | ||
| Female | 15 (17.6) | 2 (22.2) | ||
| Age | 66.0 ± 4.1 | 67.2 ± 3.9 | 0.728 | |
| cT stage | 0.028 | |||
| cT3 | 57 (70.4) | 5 (38.5) | ||
| cT4 | 24 (29.6) | 8 (61.5) | ||
| cN stage | 0.351 | |||
| cN0 | 6 (10.2) | 2 (5.7) | ||
| cN1 | 7 (11.7) | 29(82.9) | ||
| cN2 | 37 (62.1) | 3 (8.6) | ||
| cN3 | 9 (15.2) | 1 (2.8) | ||
| Siewert type | 0.005 | |||
| II | 29 (35.8) | 10 (76.9) | ||
| III | 52 (64.2) | 3 (23.1) | ||
| GTV (cm3) | 47.3 ± 27.4 | 73.2 ± 54.3 | 0.040 | |
The numbers in the parentheses are percentages. DCR: Disease control rate; PD: Progression disease; GTV: Gross tumor volume.